
- /
- Supported exchanges
- / US
- / SHPMY.PINK
Shanghai Pharmaceuticals Holding Co Ltd ADR (SHPMY PINK) stock market data APIs
Shanghai Pharmaceuticals Holding Co Ltd ADR Financial Data Overview
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. It also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Shanghai Pharmaceuticals Holding Co Ltd ADR data using free add-ons & libraries
Get Shanghai Pharmaceuticals Holding Co Ltd ADR Fundamental Data
Shanghai Pharmaceuticals Holding Co Ltd ADR Fundamental data includes:
- Net Revenue: 277 431 M
- EBITDA: 9 932 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Shanghai Pharmaceuticals Holding Co Ltd ADR Earnings data
What’s included:
- Latest Release: 2025-08-28
- EPS/Forecast: NaN
Get Shanghai Pharmaceuticals Holding Co Ltd ADR End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shanghai Pharmaceuticals Holding Co Ltd ADR News

Key Asian fuel exporters boost jet fuel sales to Europe in July, sources say
(Corrects percentage in July 2025 flight numbers compared with 2019 in paragraph 9) By Trixie Yap SINGAPORE (Reuters) -Jet fuel exports from South Korea, China and Southeast Asia to Europe likely hi...


Key Asian fuel exporters boost jet fuel sales to Europe in July, sources say
By Trixie Yap SINGAPORE (Reuters) -Jet fuel exports from South Korea, China and Southeast Asia to Europe likely hit a multi-year high in July as traders shipped out excess regional supply to cash in ...

HUTCHMED to Divest 45% Equity Stake in Shanghai Hutchison Pharmaceuticals for $608 Million
HUTCHMED (HCM) said Wednesday it has agreed to sell a 45% equity interest in Shanghai Hutchison Phar PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...

HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture
HUTCHMED (China) Limited — HUTCHMED continues to deliver on its strategy outlined in November 2022 to create value, prioritize its portfolio and bring innovative medicines to patients globally �...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.